Shanghai Haohai Biological Technology Co., Ltd. (688366.SS)
CNY 61.2
(2.02%)
CNY 61.2
(2.02%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.45 Billion CNY | 18.6% |
| 2022 | 1.22 Billion CNY | 18.85% |
| 2021 | 1.03 Billion CNY | 19.31% |
| 2020 | 865.07 Million CNY | -6.9% |
| 2019 | 929.18 Million CNY | 20.92% |
| 2018 | 768.41 Million CNY | 19.71% |
| 2017 | 641.87 Million CNY | 60.65% |
| 2016 | 399.55 Million CNY | 30.5% |
| 2015 | 306.17 Million CNY | 29.21% |
| 2014 | 236.94 Million CNY | 29.05% |
| 2013 | 183.6 Million CNY | 50.79% |
| 2012 | 121.76 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 370.46 Million CNY | 6.88% |
| 2024 Q3 | 369.41 Million CNY | -0.28% |
| 2024 Q1 | 346.62 Million CNY | 8.21% |
| 2023 FY | 1.45 Billion CNY | 18.6% |
| 2023 Q4 | 320.33 Million CNY | -20.11% |
| 2023 Q3 | 400.98 Million CNY | 13.2% |
| 2023 Q2 | 354.21 Million CNY | 9.43% |
| 2023 Q1 | 323.68 Million CNY | 22.75% |
| 2022 FY | 1.22 Billion CNY | 18.85% |
| 2022 Q4 | 263.7 Million CNY | -30.02% |
| 2022 Q3 | 376.81 Million CNY | 11.92% |
| 2022 Q2 | 336.67 Million CNY | 41.94% |
| 2022 Q1 | 237.19 Million CNY | -24.44% |
| 2021 Q3 | 239.58 Million CNY | 13.99% |
| 2021 Q4 | 313.92 Million CNY | 31.03% |
| 2021 FY | 1.03 Billion CNY | 19.31% |
| 2021 Q2 | 210.17 Million CNY | 9.66% |
| 2021 Q1 | 191.65 Million CNY | -0.97% |
| 2020 Q1 | 183.88 Million CNY | -29.59% |
| 2020 Q4 | 193.53 Million CNY | -21.81% |
| 2020 Q3 | 247.5 Million CNY | -0.25% |
| 2020 Q2 | 248.13 Million CNY | 34.94% |
| 2020 FY | 865.07 Million CNY | -6.9% |
| 2019 Q4 | 261.14 Million CNY | 23.95% |
| 2019 FY | 929.18 Million CNY | 20.92% |
| 2019 Q1 | 161.69 Million CNY | -14.87% |
| 2019 Q3 | 210.69 Million CNY | -10.5% |
| 2019 Q2 | 235.4 Million CNY | 45.59% |
| 2018 FY | 768.41 Million CNY | 19.71% |
| 2018 Q4 | 189.92 Million CNY | 0.0% |
| 2018 Q3 | 189.92 Million CNY | 1.87% |
| 2018 Q1 | 186.43 Million CNY | 0.24% |
| 2018 Q2 | 186.43 Million CNY | 0.0% |
| 2017 FY | 641.87 Million CNY | 60.65% |
| 2017 Q4 | 185.98 Million CNY | 0.0% |
| 2017 Q3 | 185.98 Million CNY | 30.07% |
| 2017 Q2 | 142.98 Million CNY | 0.0% |
| 2017 Q1 | 142.98 Million CNY | 19.02% |
| 2016 Q2 | 80.84 Million CNY | 0.0% |
| 2016 Q4 | 120.13 Million CNY | 0.0% |
| 2016 Q3 | 120.13 Million CNY | 48.61% |
| 2016 Q1 | 80.84 Million CNY | -4.6% |
| 2016 FY | 399.55 Million CNY | 30.5% |
| 2015 FY | 306.17 Million CNY | 29.21% |
| 2015 Q3 | 84.74 Million CNY | 58.34% |
| 2015 Q2 | 53.51 Million CNY | 0.0% |
| 2015 Q1 | 53.51 Million CNY | -18.1% |
| 2015 Q4 | 84.74 Million CNY | 0.0% |
| 2014 Q1 | 53.72 Million CNY | 0.77% |
| 2014 Q4 | 65.34 Million CNY | 0.0% |
| 2014 Q2 | 53.72 Million CNY | 0.0% |
| 2014 FY | 236.94 Million CNY | 29.05% |
| 2014 Q3 | 65.34 Million CNY | 21.62% |
| 2013 Q2 | 38.48 Million CNY | 0.0% |
| 2013 Q3 | 53.31 Million CNY | 38.55% |
| 2013 Q4 | 53.31 Million CNY | 0.0% |
| 2013 FY | 183.6 Million CNY | 50.79% |
| 2013 Q1 | 38.48 Million CNY | 0.0% |
| 2012 FY | 121.76 Million CNY | 0.0% |